Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

416

HTML

3842

Figures (1-5)

166

Tables (1-4)

146

Sum=4570

Sep 21, 2011 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 21, 2011; 17(35): 4023-4030
Published online Sep 21, 2011. doi: 10.3748/wjg.v17.i35.4023

Table 1 Antibodies used for immunohistochemistry

Antibody	Dilution	Company	Non-neoplastic tissue	Aberrant expression in cancer
Notch 1	0.111	Santa Cruz	Variable	Cytoplasm/nucleus
Notch 2	0.111	Santa Cruz	Variable	Cytoplasm/nucleus
Notch 3	0.111	Santa Cruz	Variable	Cytoplasm/nucleus
Notch 4	1:50	Santa Cruz	Variable	Cytoplasm/nucleus
DLL4	1:50	Sigma	Variable	Cytoplasm/nucleus

DLL4: Delta-like ligand-4.

Citation: Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030
URL: https://www.wjgnet.com/1007-9327/full/v17/i35/4023.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i35.4023